SCHEMBL5887678

SCHEMBL5887678

Cc1ccc(C2=C(c3cc(C(F)(F)F)c4ccccc4c3)[CH]CC=C2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 2/20 0.35
HSD17B2 P37059 2/20 0.35
AR P10275 1/20 0.34
BACE1 P56817 1/20 0.33
HSD11B1 P28845 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2A6 P11509 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31
ACHE P22303 1/20 0.31
TRPV1 Q8NER1 1/20 0.31
ENPP1 P22413 1/20 0.30
KCNJ11 Q14654 1/20 0.30
GPR84 Q9NQS5 1/20 0.30
S1PR1 P21453 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5887049 0.80 ENPP1 (0.33) ARHSD11B1KDM4EALDH1A1HPGD
SCHEMBL5887562 0.74 GPR84 (0.36) CYP1A2CYP2A6KDM4EALDH1A1HPGD
SCHEMBL6047621 0.69 HSD17B1 (0.37) HSD17B1HSD17B2BACE1KDM4ECYP11B1
SCHEMBL5887363 0.69 KDM4E (0.35) KDM4EALDH1A1HPGD
SCHEMBL7834790 0.68 CYP1A2 (0.55) HSD17B1HSD17B2BACE1HSD11B1CYP1A2
SCHEMBL5887681 0.66 IDO1 (0.37)
SCHEMBL28527271 0.63 CYP1A2 (0.43) HSD17B1HSD17B2BACE1HSD11B1CYP1A2
SCHEMBL28838150 0.61 MEN1 (0.46) ARHSD11B1CYP1A2CYP2A6KDM4E
SCHEMBL5887354 0.61 SMN1; SMN2 (0.38) ALDH1A1HPGD
SCHEMBL11073716 0.61 BACE1 (0.47) HSD17B1HSD17B2BACE1HSD11B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed